Related by context. All words. (Click for frequent words.) 63 Anticalins ® 63 LNP formulations 63 Anticalins R 61 splice variants 61 staphylococcal vaccine 61 antisense oligonucleotides 61 bispecific 61 lipid nanoparticles 60 prostanoid 60 DiLA2 60 siRNAs targeting 60 pharmacodynamic markers 60 mda 7 60 antisense compounds 60 DiLA2 Platform 59 immune modulating 59 TLR agonists 59 siRNA knockdown 59 novel anticancer 59 therapeutic monoclonal antibodies 59 theranostic 59 peptide antigens 59 preclinical efficacy 59 rxRNA 59 cytostatic 58 ddRNAi 58 ZFP TF 58 GMX# 58 DsiRNA 58 site directed mutagenesis 58 preclinically 58 TLR antagonists 58 BioSilicon 58 therapeutic monoclonal antibody 58 synthetic peptides 58 druggable targets 58 Nanobodies ® 58 immunoregulatory 58 sd rxRNA 57 vascular disrupting agents 57 ZFP TFs 57 OncoVEX 57 biologic therapeutics 57 PI3K/mTOR 57 TÎ ² 4 57 antitumoral 57 Exelixis compounds 57 Sangamo ZFP technology 57 nanomedicines 57 selective inhibition 57 histone deacetylase inhibitor 57 eTag assays 57 rxRNA ™ compounds 57 JAK2 inhibitor 57 siRNA therapeutic 57 isoform selective 57 SGLT2 inhibitors 57 vinca alkaloid 57 CYT# potent vascular disrupting 57 Elvitegravir 57 Smac mimetic 57 antimitotic 57 maturation inhibitors 57 DNA methyltransferases 57 THR beta agonist 57 immune modulatory 57 proteins peptides 57 Anticalins 57 pharmacokinetics pharmacodynamics 57 HCV protease inhibitors 57 polymer conjugate technology 57 Imprime PGG 57 acetylcholinesterase AChE 57 novel peptide 57 microtubule inhibitor 57 humanized monoclonal antibodies 57 PI3K/Akt pathway inhibitor 57 ALN TTR# 57 microarray gene expression 57 lentiviral vectors 57 Vaxfectin R adjuvant 57 erythropoietic 57 peptide conjugated 57 peptidic 57 Spiegelmers 57 SIRT1 activators 57 ENMD # 56 intercellular signaling 56 florbetaben 56 short interfering RNA 56 siRNA sequences 56 novel immunomodulatory 56 LHRH antagonists 56 HuLuc# 56 peptidomimetic 56 Smac mimetics 56 antagomirs 56 small molecule activators 56 siRNA duplexes 56 potent cytotoxic 56 Tß4 56 targeted antifolate 56 potent inhibitors 56 Fc fusion protein 56 TKM ApoB 56 optical biosensors 56 synthetic siRNA 56 Prodarsan ® 56 delipidation 56 therapeutically relevant 56 pharmacodynamic parameters 56 EndoTAGTM 1 56 siRNA mediated 56 AtuRNAi 56 evaluating satraplatin 56 pertuzumab 56 oxidative stress inducer 56 immunomodulatory 56 recombinant antibodies 56 PORxin TM 56 Spiegelmer ® 56 anti CD# antibodies 56 LEX System 56 druggable 56 reverse transcriptase inhibitors 56 microRNA profiling 56 NanoCrystal Technology 56 Squalamine 56 enzymatically active 56 TLR9 agonist 56 fusion enhancers 56 chimeric monoclonal antibody 56 beta Estradiol 56 Tarvacin TM 56 HERmark assay 56 kidney urologic 56 protein tyrosine phosphatases 56 selective adenosine 56 Cerashield 56 PORxin 56 norepinephrine reuptake inhibition 56 Resten NG 56 CCX# 56 selective serotonin 2C receptor 56 opioid antagonists 55 MTP inhibitor 55 indibulin 55 GnRH analogues 55 coronary stent merged 55 LentiVector 55 physico chemical properties 55 anticancer therapeutics 55 TLR9 agonists 55 signal transduction inhibitors 55 Preclinical studies suggest 55 HGS# 55 Vaxfectin R 55 combinatorial libraries 55 HSP# inhibitor 55 therapeutic peptide 55 immunomodulation 55 mertansine 55 pharmaceutically relevant 55 CCR9 antagonist 55 RNAi compounds 55 Sphingomab 55 ActA 55 antiangiogenic 55 EP #R 55 p#/CBP 55 proprietary PEGylation 55 Deforolimus 55 HDAC inhibition 55 targeting PCSK9 55 anti CD3 55 rxRNA TM compounds 55 MediVas 55 mTOR inhibition 55 NP2 Enkephalin 55 ADME properties 55 siRNA therapeutics 55 histone deacetylase inhibitors 55 ganetespib 55 physicochemical 55 VDAs 55 morpholino 55 sphingolipid 55 proteomics bioinformatics 55 brostallicin 55 phage display libraries 55 Vaxfectin 55 Viprovex TM 55 liposomal delivery 55 XP #L 55 Nanobody ® 55 Azedra ™ 55 alemtuzumab MS 55 Locked Nucleic Acid LNA 55 XmAb# 55 CobaCyte 55 developing TB4 55 optimized siRNA 55 efficacy tolerability 55 enzastaurin 55 Oral NKTR 55 single stranded oligonucleotides 55 PET tracers 55 catalytic antibodies 55 p# inhibitor 55 preclinical pharmacokinetic 55 TriRima 55 alkylating 55 QTinno TM 55 pharmacodynamic PD 55 telomerase inhibitor 55 NEUGENE antisense 55 Hedgehog inhibitor 55 biocatalytic 55 toxicogenomics 55 hapten 55 Curaxins 55 NTDDS 55 multiplexed assays 55 favorable pharmacokinetic profile 55 Lauriad 55 CellPort Technologies 55 radiolabeled TM# 55 tiapamil 55 nucleosides 55 obatoclax 55 DepoVax 55 targeting moieties 55 MT1 MMP 55 monoclonal antibody therapeutics 55 delafloxacin 55 nucleoside 55 FGFR 55 epigenetic therapies 55 artemisinin derivative 55 Mass Spectrometry MS 55 epigenetic therapeutics 55 APTIMA HPV 54 DepoVax TM 54 BiTE 54 Aviptadil 54 protein tyrosine kinase 54 recombinant albumin 54 Aganocide ® 54 systemic RNAi 54 PDE# inhibitors 54 radiolabeled monoclonal antibody 54 shRNAs 54 hydrophobic docetaxel prodrug nanoparticle 54 Adnectin 54 diagnostic biomarkers 54 antiangiogenesis 54 tranilast 54 dimensional nanostructures 54 bioinformatic approaches 54 EndoTAG TM 54 PI3K inhibitor 54 liposome encapsulated 54 TransVax tm 54 purine analog 54 bicyclic 54 vascular disrupting agent 54 EHT AGN 54 radiolabeling 54 either acutely decompensated 54 Therapeutic Diagnostics 54 EGFR tyrosine kinase inhibitors 54 NovaBay Aganocide compounds 54 siRNA reagents 54 LEAPS TM 54 IAP inhibitor 54 Vaxfectin TM 54 selectively inhibit 54 meganuclease 54 XTEN 54 UsiRNAs 54 HSP# inhibitors 54 retroviral vectors 54 humanized antibody 54 glycosylated 54 deforolimus 54 anti angiogenic drugs 54 small molecule defensin 54 monomeric 54 regenerative medicine therapies 54 DiLA 2 54 pharmacologic agents 54 kinase inhibition 54 comparative genomic hybridization 54 geldanamycin 54 Zalypsis 54 genomic biomarker 54 resolvins 54 ARIKACE ™ 54 liposomal formulation 54 Therapeutic antibodies 54 PEGylated 54 Tyrima 54 SERCA2a 54 AKT inhibitor 54 mitochondrial toxicity 54 Camptothecin 54 adipiplon 54 diagnostic molecular imaging 54 U1 Adaptors 54 TLR8 54 RhuDex ® 54 biosynthetic 54 IMiDs R 54 PDE4 inhibitor 54 AMPAKINE 54 alvespimycin 54 DexaSite 54 biased ligands 54 gene expression microarrays 54 experimentally validated 54 Epothilones 54 OvaRex R 54 Anticalin ® 54 fosbretabulin 54 oligonucleotide therapeutics 54 throughput RNAi 54 chemosensitivity 54 Fleximer 54 MediGene focuses 54 trans splicing 54 peptide fragments 54 proprietary transdermal 54 immunotoxins 54 ritonavir boosted protease inhibitor 54 PDE4 inhibitors 54 nonviral gene therapy 54 effector function 54 Elotuzumab 54 OXIGON TM 54 Endotis 54 KL4 surfactant 54 neratinib 54 aptamer therapeutics 54 Kosan dependence 54 phenotypic expression 54 immunostimulatory 54 mTOR inhibitors 54 class mGluR5 inhibitor 54 cilengitide 54 multitargeted 54 RNA antagonists 54 AvalonRx R 54 investigational HCV polymerase 54 nonviral 54 HepDirect R 54 JAK inhibitor 54 A3 adenosine receptor 54 Meta analyzes 54 antiapoptotic 54 engineered RAP peptides 54 potentiator 54 metaglidasen 54 receptor inhibitor 54 siRNA compounds 54 HQK 54 HCV antiviral 54 protein kinase inhibitors 54 nonlinear optical 54 Cloretazine R 54 blood clot dissolver 54 GPR# agonist 54 Vilazodone 54 tkRNAi technology 54 microRNA biomarkers 54 anti secretory 54 OvaRex MAb 54 immune modulation 54 orally bioavailable 54 Chrysalin 54 anticancer agents 53 Symadex 53 Myolimus 53 PI3K delta 53 iRGD 53 CCR5 inhibitor 53 Fc receptor 53 GI motility disorders 53 EGS# 53 histone deacetylase HDAC inhibitors 53 osteogenic 53 epothilones 53 nanocarriers 53 drug metabolizing enzymes 53 DEEP AF 53 oral talactoferrin 53 antiangiogenic agent 53 MGd 53 iroxanadine 53 targeted radiotherapeutic 53 G Protein Coupled 53 pharmacodynamic profile 53 enzyme immunoassay EIA 53 endophenotypes 53 Panzem R NCD 53 thalidomide Thalomid 53 TMPRSS2 ERG fusion 53 deacetylase inhibitors 53 retaspimycin 53 BEMA TM Fentanyl 53 Trofex 53 Dalbavancin 53 XmAb 53 MALDI-TOF/TOF 53 Multivariate logistic regression 53 clinicopathological 53 protein kinase inhibitor 53 Factor VIIa 53 immunomodulator 53 genomic biomarkers 53 Ampligen R 53 Zysolin TM 53 small molecule inhibitors 53 LentiVector technology 53 metabonomics 53 transdermal gel 53 Micromet BiTE 53 oral PTH 53 GPR# agonists 53 selective androgen receptor modulators 53 potent antiproliferative 53 Dyax phage display 53 MEK inhibitors 53 triphendiol 53 cyclophilin inhibitors 53 IL #p# 53 antibody cytokine 53 PEGylated interferon 53 γ secretase 53 nanoviricide 53 fatty acid biosynthesis 53 Cyclosert 53 tolerability pharmacokinetics 53 ZFP technology 53 GLP toxicology studies 53 enzyme inhibitor 53 biophysical techniques 53 antitumour 53 orally bioavailable mimics 53 LEAPS construct 53 evaluating tivozanib 53 immunotoxin 53 Bicifadine 53 small molecule tyrosine 53 prodrugs 53 vivo validation 53 CB2 receptor 53 immune stimulatory 53 agonist antagonist 53 fluoropyrimidine 53 IGFBP2 53 Azedra 53 R baclofen 53 pyrimidine 53 glycolytic 53 oligonucleotide microarrays 53 antithrombotic 53 metabolomic profiling 53 Cytolin R 53 Immunotherapeutic 53 Aganocide 53 Sudhir Agrawal D.Phil 53 prostacyclins 53 antisense drug 53 effector protein 53 inhibit angiogenesis 53 vitro dissolution 53 IMiDs ® compound 53 rxRNA compounds 53 molecular biomarkers 53 clinico pathological 53 incretin 53 logistic regression models 53 Phase IIb III 53 human IgG1 monoclonal 53 Trofile assay 53 synthetic siRNAs 53 ALN PCS 53 novel immunotherapeutic 53 vitro antiviral 53 oncolytic virus 53 adrenergic regulation 53 RGB # 53 buccal delivery 53 enantiomers 53 Novavax VLP vaccine 53 pharmacodynamic properties 53 HuCAL antibodies 53 stimulate insulin secretion 53 hormone LHRH antagonist 53 liposomal formulations 53 bioinformatic analyzes 53 uricase 53 Oragens R 53 chromatin immunoprecipitation ChIP 53 receptor subtypes 53 tezampanel 53 ConclusionThis 53 Prodarsan R 53 Aggrastat ® tirofiban hydrochloride 53 HDL Selective Delipidation 53 neuronal nicotinic receptors NNRs 53 Fleximer R 53 radionuclide therapy 53 proteomic biomarkers 53 oral gallium 53 Immunohistochemical staining 53 Antiangiogenic 53 selective orally bioavailable 53 Homspera TM 53 anticancer activity 53 novel peptides 53 ATL# [002] 53 Nanobodies R 53 pleiotropic 53 glycosylation profile 53 cannabinor 53 nonrandomized 53 Metallophile ™ Technology 53 rhITF 53 OncoVEX GM CSF 53 targeting CD# 53 siRNA antisense 53 biomolecular interactions 53 novel emulsion formulation 53 vidofludimus 53 NADiA 53 Phase #b/#a trial 53 recombinant interferon 53 PROfusion 53 antiproliferative activity 53 predictive biomarker 53 Hemopurifier TM 53 Schisandrin B 53 patient subpopulations 53 silico prediction 53 pharmaceutically active 53 ESBA# 52 oncogenic transformation 52 IgG1 antibody 52 pharmacokinetic pharmacodynamic 52 genotype phenotype 52 investigational monoclonal antibody 52 Hemopurifier ® 52 BioFocus DPI Galapagos 52 molecularly targeted 52 enantioselective 52 immune modulator 52 simian human immunodeficiency 52 BGC# 52 antitumor 52 cystinosis patients 52 P2V TM 52 treating neuropathic pain 52 Synavive 52 PKC# 52 unnatural amino acids 52 inferential statistics 52 CYP#D# gene 52 Tekmira SNALP technology 52 #HT#A 52 SARMs 52 mechanistic insights 52 nicotinic alpha 7 52 enzyme catalysis 52 ASONEP 52 investigational therapies 52 OxBC 52 Transported Prodrug 52 POTELLIGENT ® 52 HLA molecules 52 adeno associated viruses 52 Potelligent Technology 52 pramlintide metreleptin combination 52 JAK1 52 anti CD# monoclonal 52 tPEMF tm 52 multivariate statistical 52 Umbilical cord stem cells 52 antineoplastic agents 52 bifunctional 52 anticancer therapies 52 Anticalin R 52 Enkephalin 52 selective kinase inhibitors 52 allosteric modulation 52 vivo fluorescence imaging 52 CRLX# 52 synthetic ligand 52 5 HT2C 52 affinity ligands 52 antigen sparing 52 small molecule thrombopoietin 52 vivo RNAi 52 Cloretazine 52 synthetic peptide containing 52 enzyme inhibitors 52 multidrug 52 patented Bioral R nanocochleate 52 Amplimexon 52 ubiquitin ligases 52 genetic loci 52 acadesine 52 uric acid lowering 52 VEGF receptor 52 Src inhibitors 52 synDNA TM 52 physiologic mechanisms 52 NS4A 52 pyridostigmine 52 Transdel TM 52 cyclophilin inhibitor 52 DCCR 52 incyclinide 52 Activity Assay 52 DPIV inhibitors 52 viral vectors 52 conditional logistic regression 52 humanised monoclonal antibody 52 OMP #M# 52 VEGF inhibitors 52 pharmacogenetic testing 52 immunotherapeutic approaches 52 polyketides 52 HMG CoA reductase inhibitor 52 Traficet EN 52 metabolomic profiles 52 biobetter 52 meganucleases 52 Xenopus embryos 52 favorable pharmacokinetic 52 CEQ# 52 chemotherapeutic drug 52 proteomic analysis 52 racemic mixture 52 neurotrophic 52 nucleoside tide 52 prokinetic agent 52 Apo2L 52 AVI NEUGENE 52 gemcitabine cisplatin 52 NexACT ® 52 Anticalin 52 Smarticles 52 ganaxolone 52 trastuzumab Herceptin R 52 JAK3 52 CCR5 inhibitors 52 SiMoA 52 psychopharmacologic 52 Blinatumomab 52 bortezomib Velcade 52 oilbody 52 melanocortin receptors 52 pharmacokinetic interactions 52 velafermin 52 pharmacokinetic equivalence 52 electrophysiologic 52 clevidipine 52 brain penetrant 52 CanAg 52 asymmetric catalysis 52 Curaxin 52 IgG1 antibodies 52 nitric oxide donating 52 HDL Mimetic Peptide 52 SERMs 52 antifolates 52 CaPSURE 52 KRN# 52 bioactive molecules 52 Targeted Chemotherapy 52 sirtuin modulators 52 Nektar proprietary 52 Litx 52 Nanobodies 52 optogenetic 52 celgosivir 52 biased ligand 52 nucleoside analogs 52 NEUGENE 52 osteoinductive 52 histone acetyltransferase 52 epothilone 52 SynCon ™ DNA 52 Virulizin ® 52 colorectal carcinogenesis 52 tumor suppressors cytokines 52 POTELLIGENT R 52 Bayesian statistical 52 pharmacological approaches 52 Flow cytometry 52 GAP #B# 52 pharmacological chaperone 52 Interferon alpha 52 neuroactive 52 nonparametric 52 CINQUIL 52 patented Bioral 52 NPM1 mutation 52 autologous cultured chondrocytes 52 NMDA antagonist 52 Ii protein 52 peptide receptor 52 glucagon receptor 52 CB1 antagonists 52 cystic fibrosis transmembrane 52 VeraTag 52 drug zotarolimus 52 autologous platelet gel 52 ETBs 52 YONDELIS 52 iSONEP 52 allogeneic cell 52 GPx 52 N glycan 52 paxillin 52 metaanalysis 51 apoptosis inducing 51 ibudilast 51 antiproliferative effects 51 IDO inhibitor 51 Multiple logistic regression 51 intracellular uptake 51 ImmuneY2 51 TAFA# 51 antiarrhythmic 51 erlotinib Tarceva ® 51 ONCONASE R 51 IntroductionThe 51 potent antibacterial 51 BACcel 51 oral picoplatin 51 Spiegelmers ® 51 HMGCR 51 Lenocta TM sodium stibogluconate 51 neutron diffraction 51 IMiDs ® 51 duplex siRNA 51 TLR7 51 immunomodulating 51 IMC A# 51 LC MALDI 51 Tarvacin Anti Viral 51 antiangiogenic agents 51 chemo immunotherapy 51 trimeric 51 Panzem NCD 51 COMT inhibitors 51 AMPK activators 51 JAK inhibitors 51 Vidaza ® 51 ImmunoVEX 51 MMP inhibitors 51 REG1 51 Hedgehog agonist 51 theranostics 51 enzymology 51 chromosomal rearrangement 51 auristatin 51 docetaxel emulsion 51 diagnostic prognostic 51 CA9 SCAN 51 HIV integrase inhibitors 51 YONDELIS R 51 pharmacogenetic 51 kinase assay 51 PDE4 modulators 51 PXD# 51 immunological diseases 51 Generx TM 51 dimeric 51 Stapled Peptide 51 adenosine receptor 51 NXL# 51 OXi# 51 microtubule targeting 51 cis regulatory 51 MoxDuo 51 TG# [003] 51 Transfection Reagent 51 Receptors GPCRs 51 bioabsorbable polymer 51 Skinvisible receives 51 NanoCrystal technology 51 MolecularBreeding 51 somatoform disorders 51 proteasome inhibitor 51 inhibit VEGF 51 immatics 51 detection reagents 51 FGFR2 51 long acting bronchodilator 51 SynCon TM DNA 51 CHEMSAS ® 51 pharmacological 51 validate biomarkers 51 biologic DMARDs 51 act synergistically 51 physico chemical 51 adenosine A2A 51 HYC# 51 beta lactams 51 TriGrid 51 nucleosome positioning 51 transfection reagents 51 DOS# 51 estrogen receptor modulator 51 synthases 51 CEACAM1 51 NNR Therapeutics 51 ASG 5ME 51 DPX Survivac 51 pyrimidines 51 EML4 ALK 51 predictive toxicology 51 SILENOR 51 immunohistochemical 51 Capsulution 51 nucleotide analogs 51 Onconase 51 IVIVC 51 AMACR 51 PI3K inhibitors 51 Ampakine compounds 51 metabolite profiling 51 sirtuin activators 51 Dataflow Manager 51 predictive biomarkers 51 BACcel ™ system 51 Lixivaptan 51 nucleic acids proteins 51 toxicogenomic 51 Rosetta Genomics microRNA 51 RT qPCR 51 convergent validity 51 RGD peptide 51 intranasal delivery 51 ghrelin antagonist 51 DP VPA 51 endothelin antagonist 51 #ME# 51 plasma lipid 51 proteasome inhibitors 51 CyPath ® 51 oncolytic viruses 51 oncolytic 51 anticancer treatments 51 Tocomin ® ™ 51 anti angiogenic agents 51 drugable targets 51 proprietary biomaterials 51 Hyphanox 51 chimeric protein 51 MAbs targeting 51 nonpharmacologic 51 Zoraxel 51 telomerase activator 51 mGluR5 antagonist 51 pathogenetic 51 mecamylamine 51 aCGH 51 Talabostat 51 Vidaza azacitidine 51 homocysteine assay 51 cathepsins 51 pomalidomide 51 AvalonRx ® 51 nucleoside tide analogs 51 situ gelling 51 apolipoproteins 51 Modrenal 51 oral prodrug 51 Biomerk Tumorgrafts 51 amphiphilic 51 regenerative stem cell 51 peripherally acting 51 targeted anticancer therapies 51 immunotherapeutics 51 doxorubicin HCl 51 Anavex #-# 51 dermal patch 51 Nanobody 51 TPI ASM8 51 hESC derived cardiomyocytes 51 KinomeScan 51 antibiofilm 51 JAK2 inhibitors 51 immunotherapeutic vaccine 51 M1 muscarinic 51 immuno modulatory 51 micellar 51 vorinostat 51 cardiometabolic disorders 51 lamivudine zidovudine 51 Golimumab 51 urate lowering 51 PPARγ 51 Cyclin E 51 Gleevec resistant 51 pharmacogenomic tests 51 bexarotene 51 IAP inhibitors 51 oral salmon calcitonin 51 multivariate regression 51 insulin sensitizers 51 MGN# 51 toxicologic 51 optimal dosing regimens 51 Alequel ™ 51 inbred strains 51 stated Harry Stylli 51 mass spectrometric 51 siRNA delivery 51 etiologic 51 EGFR antibodies 51 therapeutic modality 51 transfection efficiency 51 CINOD 51 viral proteins 51 includes GeckoNav GeckoChat 51 topical formulations 51 insulin sensitizing 51 thrombopoietin 51 CGEN # 51 tumor necrosis 51 JAK3 inhibitor 51 lipid nanoparticles LNPs 51 COX enzymes 51 Aplidin 51 PSN# [002] 51 immunohistochemical analysis 51 antidiabetic 51 Aethlon ADAPT ™ 51 Zoraxel TM 51 chemometrics 51 covalent drugs 51 Multimeric 51 CGRP calcitonin gene 51 ZFNs clinical trials 51 purinergic receptors P#X# 51 tumor antigens 51 novel anti infective 51 organophosphorus compounds 51 nucleoside analog 51 antisense RNA 51 chemoinformatics 51 pancreatic enzyme replacement 51 glycomics 51 anticoagulant reversing agent 51 potent anticancer 51 inhibiting tumor 51 Spinal cord stimulation 51 Tasimelteon 51 Caliber Therapeutics 51 antithrombotics 51 Mammostrat 51 ALN RSV program 51 UltiMAb 51 metabolite identification 51 wilate ® 51 Logistic regression 51 Isis antisense 50 c MYC 50 PEG SN# 50 Syllego system 50 molecular chaperone regulation 50 iBioLaunch platform 50 lysophosphatidic acid LPA 50 urodynamic 50 preferentially bind 50 BHT DNA 50 antibody antigen 50 linear pharmacokinetics 50 comparative genomic 50 CardioPET 50 bioseparation 50 immunomodulators 50 transabdominal 50 differential gene expression 50 pan HDAC inhibitor 50 M2 subunit 50 nutlin 50 anti neoplastic 50 noninfectious uveitis 50 proprietary LNA 50 proteolytic 50 calcineurin inhibitors 50 neuroregenerative 50 antiproliferative